Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Sernova.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Sernova
Canada Flag
Country
Country
Canada
Address
Address
700 Collip Circle, Ste 114 London, ON, Canada N6G 4X8
Telephone
Telephone
1.877.299.4603

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Under the collaboration, AstraZeneca will explore the use of Sernova’s Cell Pouch System as a potential platform for integration with its development of the next wave of innovative cell therapies for various indications.


Lead Product(s): Undisclosed

Therapeutic Area: Endocrinology Product Name: Undisclosed

Highest Development Status: PreclinicalProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: AstraZeneca

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration May 03, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Sernova’s Cell Pouch System™ (human donor islets cell) is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells.


Lead Product(s): Human Donor Islets Cell,Undisclosed

Therapeutic Area: Endocrinology Product Name: Sernova Cell Pouch

Highest Development Status: Phase I/ Phase IIProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 08, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Sernova’s Cell Pouch System is a novel implant consisting human islets cells, which allows for reestablishment of production of triiodothyronine (T3) and thyroxine (T4) and the hypothalamic-pituitary-thyroid axis, to preserve thyroid function following total thyroidectomy.


Lead Product(s): Human Donor Islets Cell

Therapeutic Area: Endocrinology Product Name: Sernova Cell Pouch

Highest Development Status: Phase I/ Phase IIProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 30, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Sernova’s Cell Pouch System™ (human donor islets cell) is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells.


Lead Product(s): Human Donor Islets Cell,Undisclosed

Therapeutic Area: Endocrinology Product Name: Sernova Cell Pouch

Highest Development Status: Phase I/ Phase IIProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Evotec

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 10, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Human Donor Islets Cell are transplanted into the Sernova Cell Pouch approximately six weeks after Cell Pouch implantation to allow development of fully vascularized native tissue chambers and achieve a stable immunosuppressant regimen.


Lead Product(s): Human Donor Islets Cell

Therapeutic Area: Endocrinology Product Name: Sernova Cell Pouch

Highest Development Status: Phase I/ Phase IIProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 17, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

The Cell Pouch is implantable device, that is transplanted with therapeutic cells such as Sernova Cell Pouch (insulin producing islets). Combination product is designed for treatment of Type 1 Diabetes Mellitus with hypoglycemia.


Lead Product(s): Human Donor Islets Cell

Therapeutic Area: Endocrinology Product Name: Sernova Cell Pouch

Highest Development Status: Phase I/ Phase IIProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 03, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Sernova will use the net proceeds from the common shares for general working capital purposes and to continue pursuing ‘functional cures’ for diabetes, hypothyroidism and hemophilia A by using Human donor islets cell (Sernova Cell Pouch).


Lead Product(s): Human Donor Islets Cell,Undisclosed

Therapeutic Area: Endocrinology Product Name: Sernova Cell Pouch

Highest Development Status: Phase I/ Phase IIProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Evotec

Deal Size: $270.0 million Upfront Cash: Undisclosed

Deal Type: Financing September 01, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY